# FDA Inspection 1217732 - Guilin Pharmaceutical Co., Ltd. - August 18, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/guilin-pharmaceutical-co-ltd/330fef8b-c36c-41fe-beb1-3e7344d42db6
Source feed: FDA_Inspections

> FDA Inspection 1217732 for Guilin Pharmaceutical Co., Ltd. on August 18, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1217732
- Company Name: Guilin Pharmaceutical Co., Ltd.
- Inspection Date: 2023-08-18
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1061489 - 2018-07-19](https://www.globalkeysolutions.net/records/fda_inspections/guilin-pharmaceutical-co-ltd/b4eb333f-6776-4112-b186-4dad9d53ea0e)
- [FDA Inspection 920262 - 2015-03-13](https://www.globalkeysolutions.net/records/fda_inspections/guilin-pharmaceutical-co-ltd/bc267894-3da3-4573-a4f7-e1cae0079a7e)
- [FDA Inspection 748950 - 2011-09-02](https://www.globalkeysolutions.net/records/fda_inspections/guilin-pharmaceutical-co-ltd/ca937f37-9eed-4f12-8c95-c2f06924b4ff)

Company: https://www.globalkeysolutions.net/companies/guilin-pharmaceutical-co-ltd/8a53776f-b81a-417d-b1c5-ea1cd2d0b0a8

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c